ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Brief report

Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

Terapia de sellado de catéteres: ¿reduce la heparina la bioactividad de la dalbavancina cuando están juntas en solución durante congelación?

Marta Díaz-Navarroa,b, Rama Hafianc, María Jesús Pérez-Grandaa,b,d, Emilia Cercenadoa,e, Patricia Muñoza,b,d,e, María Guembea,b,

Corresponding author

maria.guembe@iisgm.com

Corresponding author.

a Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain

b Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

c Biology Department, School of Biology, Universidad Complutense de Madrid, Spain

d CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain

e Medicine Department, School of Medicine, Universidad Complutense de Madrid, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2024.02.005

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 July	1	0	1
2024 April	30	2	32
2024 March	9	6	15

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Uncommon lip lesions in an HIV...

10.1016/j.eimc.2024.06.017

Tolerance of Atovacuona/proguanil in off-label...

10.1016/j.eimc.2024.06.012

Resumen ejecutivo de las Guías Española de...

Enferm Infecc Microbiol Clin. 2024;42:380-5

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter